Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 310

1.

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.

Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N.

Ann Rheum Dis. 2019 Nov;78(11):1592-1600. doi: 10.1136/annrheumdis-2019-215933. Epub 2019 Sep 9.

PMID:
31501138
2.

The challenges of gout flare reporting: mapping flares during a randomized controlled trial.

Teoh N, Gamble GD, Horne A, Taylor WJ, Palmano K, Dalbeth N.

BMC Rheumatol. 2019 Jul 9;3:27. doi: 10.1186/s41927-019-0075-6. eCollection 2019.

3.

Evaluating the effectiveness of therapeutic horse riding for children and young people experiencing disability: a single-case experimental design study.

Martin RA, Taylor WJ, Surgenor LJ, Graham FP, Levack WMM, Blampied NM.

Disabil Rehabil. 2019 May 13:1-10. doi: 10.1080/09638288.2019.1610083. [Epub ahead of print]

PMID:
31084288
4.

Use of multi-attribute decision-making to inform prioritization of Cochrane review topics relevant to rehabilitation.

Taylor WJ, Green SE.

Eur J Phys Rehabil Med. 2019 Jun;55(3):322-330. doi: 10.23736/S1973-9087.19.05787-3. Epub 2019 Apr 3.

5.

Scoping review of priority setting of research topics for musculoskeletal conditions.

Bourne AM, Johnston RV, Cyril S, Briggs AM, Clavisi O, Duque G, Harris IA, Hill C, Hiller C, Kamper SJ, Latimer J, Lawson A, Lin CC, Maher C, Perriman D, Richards BL, Smitham P, Taylor WJ, Whittle S, Buchbinder R.

BMJ Open. 2018 Dec 16;8(12):e023962. doi: 10.1136/bmjopen-2018-023962.

6.

Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network.

Buchbinder R, Bourne A, Latimer J, Harris I, Whittle S, Richards B, Taylor WJ, Clavisi O, Green S, Hinman RS, March L, Day R, Ferreira ML, Billot L, Maher CG; ANZMUSC Clinical Trial Network.

Intern Med J. 2018 Dec 11. doi: 10.1111/imj.14191. [Epub ahead of print] Review.

PMID:
30548385
7.

The International Consortium for Health Outcome Measurement (ICHOM)Set of Outcomes that Matter to People Living with Inflammatory Arthritis Consensus from an international Working Group.

Oude Voshaar MAH, Das Gupta Z, Bijlsma JWJ, Boonen A, Chau J, Courvoisier DS, Curtis JR, Ellis B, Ernestam S, Gossec L, Hale C, Hornjeff J, Leung KYY, Lidar M, Mease P, Michaud K, Mody GM, Ndosi M, Opava CH, Pinheiro GRC, Salt M, Soriano ER, Taylor WJ, Voshaar MJH, Weel AEAM, de Wit M, Wulffraat N, van de Laar MAFJ, Vonkeman HE.

Arthritis Care Res (Hoboken). 2018 Oct 24. doi: 10.1002/acr.23799. [Epub ahead of print]

PMID:
30358135
8.

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.

Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Scarpa R, Marchesoni A, Taylor WJ, Salvarani C, Kalden J, Lubrano E, Carneiro S, Piga M, Floris A, Desiati F, Flynn JA, D'Angelo S, van Kuijk AWR, Catanoso MG, Caso F, Contu P, Ujfalussy I, Helliwell PS, Mease PJ; GRAPPA 3PPsA Study Group.

J Rheumatol. 2018 Aug;45(9):1256-1262. doi: 10.3899/jrheum.171183. Epub 2018 Jun 15.

PMID:
29907666
9.
10.

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.

Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, da Rocha Castelar-Pinheiro G, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2019 Mar;71(3):427-434. doi: 10.1002/acr.23607.

PMID:
29799677
11.

The nomenclature of the basic disease elements of gout: A content analysis of contemporary medical journals.

Bursill D, Taylor WJ, Terkeltaub R, Dalbeth N.

Semin Arthritis Rheum. 2018 Dec;48(3):456-461. doi: 10.1016/j.semarthrit.2018.03.017. Epub 2018 Mar 28.

PMID:
29706241
12.

Predictors of activity limitation in people with gout: a prospective study.

Stewart S, Rome K, Eason A, House ME, Horne A, Doyle AJ, Knight J, Taylor WJ, Dalbeth N.

Clin Rheumatol. 2018 Aug;37(8):2213-2219. doi: 10.1007/s10067-018-4110-6. Epub 2018 Apr 21.

PMID:
29680870
13.

Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.

Stamp L, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

Semin Arthritis Rheum. 2018 Oct;48(2):293-301. doi: 10.1016/j.semarthrit.2018.02.009. Epub 2018 Feb 21.

PMID:
29566967
14.

Response to: 'The reference levels of serum urate for clinically evident incident gout' by Chen and Ding.

Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR.

Ann Rheum Dis. 2019 May;78(5):e42. doi: 10.1136/annrheumdis-2018-213372. Epub 2018 Mar 21. No abstract available.

PMID:
29563107
15.

Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.

Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR.

Ann Rheum Dis. 2018 Jul;77(7):1048-1052. doi: 10.1136/annrheumdis-2017-212288. Epub 2018 Feb 20.

PMID:
29463518
16.

Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.

Stamp LK, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

J Rheumatol. 2018 Mar;45(3):419-424. doi: 10.3899/jrheum.170911. Epub 2017 Dec 15.

PMID:
29247147
17.

Mechanisms of Change for Children Participating in Therapeutic Horse Riding: A Grounded Theory.

Martin RA, Graham FP, Taylor WJ, Levack WMM.

Phys Occup Ther Pediatr. 2018;38(5):510-526. doi: 10.1080/01942638.2017.1400492. Epub 2017 Dec 13.

PMID:
29236556
18.

Allopurinol and peripheral vascular disease: enough observational data to warrant interventional studies: Allopurinol and the prevention of vascular disease.

Grainger R, Taylor WJ.

Rheumatology (Oxford). 2018 Mar 1;57(3):408-409. doi: 10.1093/rheumatology/kex354. No abstract available.

PMID:
28968915
19.

Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies.

Nielsen SM, Bartels EM, Henriksen M, Wæhrens EE, Gudbergsen H, Bliddal H, Astrup A, Knop FK, Carmona L, Taylor WJ, Singh JA, Perez-Ruiz F, Kristensen LE, Christensen R.

Ann Rheum Dis. 2017 Nov;76(11):1870-1882. doi: 10.1136/annrheumdis-2017-211472. Epub 2017 Sep 2. Review.

20.

The patient experience of musculoskeletal imaging tests for investigation of inflammatory arthritis: a mixed-methods study.

Bourke S, Taylor WJ, Doyle AJ, Gott M, Dalbeth N.

Clin Rheumatol. 2018 Aug;37(8):2261-2268. doi: 10.1007/s10067-017-3760-0. Epub 2017 Jul 20.

PMID:
28730270
21.

Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritis.

Janssens HJEM, Fransen J, Janssen M, Neogi T, Schumacher HR, Jansen TL, Dalbeth N, Taylor WJ.

Rheumatology (Oxford). 2017 Aug 1;56(8):1335-1341. doi: 10.1093/rheumatology/kex164.

PMID:
28431109
22.

Apps for People With Rheumatoid Arthritis to Monitor Their Disease Activity: A Review of Apps for Best Practice and Quality.

Grainger R, Townsley H, White B, Langlotz T, Taylor WJ.

JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e7. doi: 10.2196/mhealth.6956.

23.

Predictors of Mortality in People with Recent-onset Gout: A Prospective Observational Study.

Vincent ZL, Gamble G, House M, Knight J, Horne A, Taylor WJ, Dalbeth N.

J Rheumatol. 2017 Mar;44(3):368-373. doi: 10.3899/jrheum.160596. Epub 2016 Dec 15.

PMID:
27980010
24.

Crystal identification of synovial fluid aspiration by polarized light microscopy. An online test suggesting that our traditional rheumatologic competence needs renewed attention and training.

Berendsen D, Neogi T, Taylor WJ, Dalbeth N, Jansen TL.

Clin Rheumatol. 2017 Mar;36(3):641-647. doi: 10.1007/s10067-016-3461-0. Epub 2016 Nov 11.

PMID:
27837341
25.

Illness Perceptions and Mortality in Patients With Gout: A Prospective Observational Study.

Serlachius A, Gamble G, House M, Vincent ZL, Knight J, Horne A, Taylor WJ, Petrie KJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1444-1448. doi: 10.1002/acr.23147. Epub 2017 Aug 13.

26.

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard.

Dalbeth N, Schumacher HR, Fransen J, Neogi T, Jansen TL, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Cimmino MA, Uhlig T, Taylor WJ.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1894-1898. doi: 10.1002/acr.22896. Epub 2016 Oct 28.

27.

What Should Be the Cut Point for Classification Criteria of Studies in Gout? A Conjoint Analysis.

Fransen J, Kievit W, Neogi T, Schumacher R, Jansen T, Dalbeth N, Taylor WJ.

Arthritis Care Res (Hoboken). 2016 Nov;68(11):1731-1735. doi: 10.1002/acr.22875. Epub 2016 Oct 1.

28.

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.

Ogdie A, Taylor WJ, Neogi T, Fransen J, Jansen TL, Schumacher HR, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Cagnotto G, Cavagna L, Lin C, Chou YY, Tausche AK, Lima Gomes Ochtrop M, Janssen M, Chen JH, Slot O, Lazovskis J, White D, Cimmino MA, Uhlig T, Dalbeth N.

Arthritis Rheumatol. 2017 Feb;69(2):429-438. doi: 10.1002/art.39959.

29.

What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions.

Tatlock S, Rüdell K, Panter C, Arbuckle R, Harrold LR, Taylor WJ, Symonds T.

Patient. 2017 Feb;10(1):65-79. doi: 10.1007/s40271-016-0184-x.

30.

Gout Classification Criteria: Update and Implications.

Vargas-Santos AB, Taylor WJ, Neogi T.

Curr Rheumatol Rep. 2016 Jul;18(7):46. doi: 10.1007/s11926-016-0594-8. Review.

31.

Which aspects of health are most important for patients with spondyloarthritis? A Best Worst Scaling based on the ASAS Health Index.

Kiltz U, Essers I, Hiligsmann M, Braun J, Maksymowych WP, Taylor WJ, van der Heijde D, Boonen A.

Rheumatology (Oxford). 2016 Oct;55(10):1771-6. doi: 10.1093/rheumatology/kew238. Epub 2016 Jun 21.

PMID:
27330163
32.
33.

Factors associated with change in radiographic damage scores in gout: a prospective observational study.

Eason A, House ME, Vincent Z, Knight J, Tan P, Horne A, Gamble GD, Doyle AJ, Taylor WJ, Dalbeth N.

Ann Rheum Dis. 2016 Dec;75(12):2075-2079. doi: 10.1136/annrheumdis-2015-208937. Epub 2016 Feb 24.

PMID:
26912565
34.

Development and First Validation of a Disease Activity Score for Gout.

Scirè CA, Carrara G, Viroli C, Cimmino MA, Taylor WJ, Manara M, Govoni M, Salaffi F, Punzi L, Montecucco C, Matucci-Cerinic M, Minisola G; Study Group for the Kick-Off of the Italian Network for Gout Study.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1530-7. doi: 10.1002/acr.22844. Epub 2016 Sep 6.

35.

Pros and cons of conjoint analysis of discrete choice experiments to define classification and response criteria in rheumatology.

Taylor WJ.

Curr Opin Rheumatol. 2016 Mar;28(2):117-21. doi: 10.1097/BOR.0000000000000259. Review.

PMID:
26780423
36.

Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Ralph Schumacher H, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

J Rheumatol. 2016 Jan;43(1):150-3. doi: 10.3899/jrheum.150684. Epub 2015 Dec 1.

PMID:
26628602
37.

Imaging as a potential outcome measure in gout studies: A systematic literature review.

Durcan L, Grainger R, Keen HI, Taylor WJ, Dalbeth N.

Semin Arthritis Rheum. 2016 Apr;45(5):570-9. doi: 10.1016/j.semarthrit.2015.09.008. Review.

PMID:
26522139
38.

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.

de Lautour H, Taylor WJ, Adebajo A, Alten R, Burgos-Vargas R, Chapman P, Cimmino MA, da Rocha Castelar Pinheiro G, Day R, Harrold LR, Helliwell P, Janssen M, Kerr G, Kavanaugh A, Khanna D, Khanna PP, Lin C, Louthrenoo W, McCarthy G, Vazquez-Mellado J, Mikuls TR, Neogi T, Ogdie A, Perez-Ruiz F, Schlesinger N, Ralph Schumacher H, Scirè CA, Singh JA, Sivera F, Slot O, Stamp LK, Tausche AK, Terkeltaub R, Uhlig T, van de Laar M, White D, Yamanaka H, Zeng X, Dalbeth N.

Arthritis Care Res (Hoboken). 2016 May;68(5):667-72. doi: 10.1002/acr.22741.

39.

Editorial: Shifting the Goal Posts: Treatment Recommendations for Ankylosing Spondylitis and the Newly Defined Condition of Nonradiographic Axial Spondyloarthritis.

Taylor WJ, St Clair EW.

Arthritis Rheumatol. 2016 Feb;68(2):265-9. doi: 10.1002/art.39300. No abstract available.

40.

Measuring Neurobehavioral Functioning in People With Traumatic Brain Injury: Rasch Analysis of Neurobehavioral Functioning Inventory.

Czuba KJ, Kersten P, Kayes NM, Smith GA, Barker-Collo S, Taylor WJ, McPherson KM.

J Head Trauma Rehabil. 2016 Jul-Aug;31(4):E59-68. doi: 10.1097/HTR.0000000000000170.

41.

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ.

Ann Rheum Dis. 2015 Oct;74(10):1789-98. doi: 10.1136/annrheumdis-2015-208237. Erratum in: Ann Rheum Dis. 2016 Feb;75(2):473.

42.

2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ.

Arthritis Rheumatol. 2015 Oct;67(10):2557-68. doi: 10.1002/art.39254. Erratum in: Arthritis Rheumatol. 2016 Feb;68(2):515. Vaquez-Mellado, Janitzia [corrected to Vazquez-Mellado, Janitzia].

43.

An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.

Robinson PC, Taylor WJ, Dalbeth N.

J Rheumatol. 2015 Sep;42(9):1702-7. doi: 10.3899/jrheum.150310. Epub 2015 Aug 1.

44.

Distinctions Between Diagnostic and Classification Criteria: Comment on the Article by Aggarwal et al.

Taylor WJ, Fransen J.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):149-50. doi: 10.1002/acr.22671. No abstract available.

45.

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout.

Taylor WJ, Fransen J, Jansen TL, Dalbeth N, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, Vargas-Santos AB, Janssen M, Chen JH, Slot O, Cimmino MA, Uhlig T, Neogi T.

Arthritis Care Res (Hoboken). 2015 Sep;67(9):1304-15. doi: 10.1002/acr.22585.

46.

Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.

Grainger R, Dalbeth N, Keen H, Durcan L, Lawrence Edwards N, Perez-Ruiz F, Diaz-Torne C, Singh JA, Khanna D, Simon LS, Taylor WJ.

J Rheumatol. 2015 Dec;42(12):2460-4. doi: 10.3899/jrheum.141164. Epub 2015 Feb 1. Review.

47.

NMR studies of the chiral selectivity of self-assembled guanosinemonophosphate.

Gupta AP, Taylor WJ, McGown LB, Kempf JG.

J Phys Chem B. 2014 Dec 11;118(49):14243-56. doi: 10.1021/jp5075016. Epub 2014 Nov 26.

PMID:
25401946
48.

Updated guidelines for the management of axial disease in psoriatic arthritis.

Nash P, Lubrano E, Cauli A, Taylor WJ, Olivieri I, Gladman DD.

J Rheumatol. 2014 Nov;41(11):2286-9. doi: 10.3899/jrheum.140877. Review.

PMID:
25362712
49.

Performance of classification criteria for gout in early and established disease.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

Ann Rheum Dis. 2016 Jan;75(1):178-82. doi: 10.1136/annrheumdis-2014-206364. Epub 2014 Oct 28.

PMID:
25351521
50.

Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20).

Aati O, Taylor WJ, Siegert RJ, Horne A, House ME, Tan P, Drake J, Stamp LK, Dalbeth N.

Ann Rheum Dis. 2015 Dec;74(12):2144-50. doi: 10.1136/annrheumdis-2014-205671. Epub 2014 Aug 11.

PMID:
25114061

Supplemental Content

Loading ...
Support Center